Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Treatment Results and Malignant Complications in Patients on Long-Term Treatment with Tyrosine Kinase Inhibitors(TKIs) for Chronic Myeloid Leukemia(CML)

Taiichi Kyo, MD, Kouhei Kyo, M.D., Takesi Okatani, Mitsuhiro Itagaki, M.D., Ryouta Imanaka, M.D., Yuuta Katayama, Kouji Iwato, Hideki Asaoku, MD, Tetsurou Ohti, Megu Ohtaki, Keiko Ohtani

Blood (2012) 120 (21): 3767.

https://doi.org/10.1182/blood.V120.21.3767.3767

Published: 2012

Journal Articles

Long-Term Outcome of All-Trans-Retinoic-Acid(ATRA)+Intensive Chemotherapy in Acute Promyelocytic Leukemia(APL),

Taiichi Kyo, M.D., Takeshi Okatani, M.D., Kouhei Kyo, M.D., Mitsuhiro Itagaki, M.D., Ryouta Imanaka, M.D., Koji Iwato, M.D., Hidkeki Asaoku, M.D., Yuuta Katayama, M.D.

Blood (2011) 118 (21): 3604.

https://doi.org/10.1182/blood.V118.21.3604.3604

Published: 2011

Journal Articles

Early Diagnostic Procedure and Treatment for Invasive Fungal Infection Centered on Invasive Aspergillosis in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia

Kouhei Kyo, M.D., Takeshi Okatani, M.D., Ryota Imanaka, M.D., Mitsuhiro Itagaki, M.D., Yuuta Katayama, M.D., Taiichi Kyo, M.D.

Blood (2011) 118 (21): 1544.

https://doi.org/10.1182/blood.V118.21.1544.1544

Published: 2011

Journal Articles

Results of Treatment with Tyrosine Kinase Inhibitors(TKIs) in Combination with Intensive Chemotherapy in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia(Ph+ALL)

Taiichi Kyo, M.D., Takeshi Okatani, M.D., Kouhei Kyo, Ryouta Imanaka, M.D., Mitsuhiro Itagaki, M.D., Yuuta Katayama, MD, Koji Iwato, M.D., Hideki Asaoku, MD

Blood (2011) 118 (21): 1503.

https://doi.org/10.1182/blood.V118.21.1503.1503

Published: 2011

Journal Articles

Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)

Taiichi Kyo, MD, Noriaki Yoshida, MD, Kouhei Kyo, MD, Takeshi Okatani, MD, Mitsuhiro Itagaki, MD, Hiromi Yuasa, MD, Koji Iwato, MD, Hideki Asaoku, MD, Yuuta Katayama, MD

Blood (2010) 116 (21): 2934.

https://doi.org/10.1182/blood.V116.21.2934.2934

Published: 2010

Journal Articles

Long-Term WT1 Peptide Vaccination Over 7 Years for 3 AML Patients with Molecular Relapse

Haruo Sugiyama, MD, PhD, Akihiro Tsuboi, Yoshihiro Oka, MD, PhD, Taiichi Kyo, Yuuta Katayama, Elisseeva Olga, Manabu Kawakami, Naoki Hosen, Sumiyuki Nishida, Soyoko Morimoto, Ayako Murao, Hiroko Nakajima, Ichiro Kawase, Yusuke Oji, MD, PhD, Hiroo Dohy

Blood (2010) 116 (21): 3295.

https://doi.org/10.1182/blood.V116.21.3295.3295

Published: 2010

Journal Articles

High Remission Rates and Long-Term Survival in a High Percentage of Patients Achieved by Intensive Chemotherapy for AML and Further Improvement of Supportive Care.

Taiichi Kyo, MD, Akiko Kimura, MD, Kouhei Kyo, MD, Noriaki Yoshida, MD, Hideki Asaoku, MD, Koji Iwato, MD, Yuuta Katayama, MD, Hiromi Yuasa, MD

Blood (2009) 114 (22): 1052.

https://doi.org/10.1182/blood.V114.22.1052.1052

Published: 2009

NARROW

Treatment Results and Malignant Complications in Patients on Long-Term Treatment with Tyrosine Kinase Inhibitors(TKIs) for Chronic Myeloid Leukemia(CML)

Long-Term Outcome of All-Trans-Retinoic-Acid(ATRA)+Intensive Chemotherapy in Acute Promyelocytic Leukemia(APL),

Early Diagnostic Procedure and Treatment for Invasive Fungal Infection Centered on Invasive Aspergillosis in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia

Results of Treatment with Tyrosine Kinase Inhibitors(TKIs) in Combination with Intensive Chemotherapy in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia(Ph+ALL)

Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)

Long-Term WT1 Peptide Vaccination Over 7 Years for 3 AML Patients with Molecular Relapse

High Remission Rates and Long-Term Survival in a High Percentage of Patients Achieved by Intensive Chemotherapy for AML and Further Improvement of Supportive Care.

Email alerts

ASH Publications

American Society of Hematology

Treatment Results and Malignant Complications in Patients on Long-Term Treatment with Tyrosine Kinase Inhibitors(TKIs) for Chronic Myeloid Leukemia(CML)

Long-Term Outcome of All-Trans-Retinoic-Acid(ATRA)+Intensive Chemotherapy in Acute Promyelocytic Leukemia(APL),

Early Diagnostic Procedure and Treatment for Invasive Fungal Infection Centered on Invasive Aspergillosis in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia

Results of Treatment with Tyrosine Kinase Inhibitors(TKIs) in Combination with Intensive Chemotherapy in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia(Ph+ALL)

Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)

Long-Term WT1 Peptide Vaccination Over 7 Years for 3 AML Patients with Molecular Relapse

High Remission Rates and Long-Term Survival in a High Percentage of Patients Achieved by Intensive Chemotherapy for AML and Further Improvement of Supportive Care.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only